Combination chemotherapy with fluorouracil, adriamycin, cis-Platinum and VM-26 in advanced transitional cell carcinoma of the urinary tract
- 1 December 1986
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (12) , 1457-1460
- https://doi.org/10.1016/0277-5379(86)90079-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Comparative activity and toxicity of cis-diamminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinomas of the urinary tract.Journal of Clinical Oncology, 1985
- Cis‐diamminedichloroplatinum (DDP) as Initial Treatment of lnvasive Bladder CancerBritish Journal of Urology, 1984
- Combination chemotherapy with cisplatin and VM-26 in advanced transitional cell carcinoma of the bladderEuropean Journal of Cancer and Clinical Oncology, 1984
- Chemotherapy of advanced transitional cell carcinoma of the uroepitheliumCancer Chemotherapy and Pharmacology, 1983
- Phase-II trials in patients with urothelial tract tumorsCancer Chemotherapy and Pharmacology, 1983
- A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A national bladder cancer collaborative group a studyCancer, 1983
- Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinomaAmerican Journal of Clinical Oncology, 1983
- Cyclophosphamide, adriamycin and cisplatin combination chemotherapy in advanced bladder carcinoma: an EORTC phase II studyEuropean Journal of Cancer and Clinical Oncology, 1982
- Reporting results of cancer treatmentCancer, 1981
- Chemotherapy of Metastatic Bladder CancerCancer, 1980